The optimal therapy for locally advanced, unresectable, stage III non–small-cell lung cancer (NSCLC) continues to evolve. The critical determinants of overall survival include local tumor control and the
Gary S. Gordon, MD
Advertisement
Articles by Gary S. Gordon, MD
Advertisement
Latest Updated Articles
- Chemoradiation for Locally Advanced, Unresectable NSCLC
Published: August 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
2
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
3
Forming CUTNETs: A Joint Venture Between Surgery and Oncology in NETs
4
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
5
